G Gargano

887 total citations
42 papers, 591 citations indexed

About

G Gargano is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, G Gargano has authored 42 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Reproductive Medicine, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in G Gargano's work include Ovarian cancer diagnosis and treatment (15 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Reproductive Biology and Fertility (3 papers). G Gargano is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Reproductive Biology and Fertility (3 papers). G Gargano collaborates with scholars based in Italy, United States and Switzerland. G Gargano's co-authors include M. De Lena, Annamaria Catino, Giuseppe Fanizza, Agnese Latorre, Michele Guida, Vito Lorusso, Ettore Cicinelli, Gennaro Cormio, Vera Loizzi and Antonella Mazzei and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and European Journal of Cancer.

In The Last Decade

G Gargano

41 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Gargano Italy 14 186 129 111 100 92 42 591
Zhenyu Zhang China 15 151 0.8× 52 0.4× 190 1.7× 78 0.8× 68 0.7× 39 524
Lidija Beketić-Orešković Croatia 13 288 1.5× 102 0.8× 47 0.4× 276 2.8× 101 1.1× 37 591
Yuebo Yang China 16 312 1.7× 162 1.3× 97 0.9× 215 2.1× 49 0.5× 43 944
Sophie Barrett United Kingdom 9 256 1.4× 161 1.2× 32 0.3× 295 3.0× 85 0.9× 18 660
Rutie Yin China 16 296 1.6× 160 1.2× 126 1.1× 319 3.2× 217 2.4× 120 997
Fangrong Shen China 17 346 1.9× 260 2.0× 144 1.3× 163 1.6× 98 1.1× 45 783
Georgia A. McCann United States 16 250 1.3× 135 1.0× 145 1.3× 554 5.5× 139 1.5× 37 897
Y. Nakao Japan 18 221 1.2× 35 0.3× 188 1.7× 205 2.0× 125 1.4× 48 843
Micael Lopez-Acevedo United States 11 227 1.2× 108 0.8× 122 1.1× 169 1.7× 150 1.6× 17 626
Yifeng He China 11 284 1.5× 127 1.0× 25 0.2× 279 2.8× 100 1.1× 19 910

Countries citing papers authored by G Gargano

Since Specialization
Citations

This map shows the geographic impact of G Gargano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Gargano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Gargano more than expected).

Fields of papers citing papers by G Gargano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Gargano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Gargano. The network helps show where G Gargano may publish in the future.

Co-authorship network of co-authors of G Gargano

This figure shows the co-authorship network connecting the top 25 collaborators of G Gargano. A scholar is included among the top collaborators of G Gargano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Gargano. G Gargano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vimercati, Antonella, Miriam Dellino, Francesco Maria Crupano, G Gargano, & Ettore Cicinelli. (2021). Ultrasonic assessment of cesarean section scar to vesicovaginal fold distance: an instrument to estimate pre-labor uterine rupture risk. The Journal of Maternal-Fetal & Neonatal Medicine. 35(22). 4370–4374. 23 indexed citations
2.
Dellino, Miriam, Alice Bergamini, G Gargano, et al.. (2020). Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery. Biomedicines. 8(12). 554–554. 28 indexed citations
3.
Loizzi, Vera, G Gargano, Emanuele Naglieri, et al.. (2017). Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer. International Journal of Molecular Sciences. 18(9). 1967–1967. 75 indexed citations
4.
Gargano, G, et al.. (2014). Lung recruitment strategy and surfactant in delivery room.. PubMed. 85(1). 7–10.
5.
Monari, Francesca, Salvatore Alberico, Laura Avagliano, et al.. (2011). Relation between maternal thrombophilia and stillbirth according to causes/associated conditions of death. Early Human Development. 88(4). 251–254. 14 indexed citations
6.
Gargano, G, et al.. (2003). Ovarian fibroma: our experience of 34 cases.. PubMed. 24(5). 429–32. 13 indexed citations
7.
Lena, M. De, Vito Lorusso, Agnese Latorre, et al.. (2001). Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study. European Journal of Cancer. 37(3). 364–368. 150 indexed citations
8.
Lorusso, Vito, Giovanni Di Vagno, Luigi Manzione, et al.. (1998). Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study. Gynecologic Oncology. 68(2). 172–177. 5 indexed citations
9.
Lena, M. De, Vito Lorusso, Mario Brandi, et al.. (1997). Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum.. Journal of Clinical Oncology. 15(10). 3208–3213. 28 indexed citations
10.
Correale, M., Ines Abbate, Angelo Paradiso, et al.. (1993). pS2—A new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer. Cell Biochemistry and Biophysics. 22(1-3). 101–110. 3 indexed citations
11.
Correale, M., Ines Abbate, G Gargano, et al.. (1993). Serum and cytosolic levels of CA549 in breast cancer patients.. PubMed. 20(4). 264–7. 1 indexed citations
12.
Lorusso, Vito, Annamaria Catino, B Leone, et al.. (1993). Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study.. Journal of Clinical Oncology. 11(10). 1952–1956. 15 indexed citations
13.
Correale, M., Ines Abbate, G Gargano, et al.. (1992). Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29.. PubMed. 7(1). 43–6. 3 indexed citations
14.
Gargano, G. (1992). Prognostic factors in epithelial ovarian cancer.. PubMed. 13(1). 45–52. 5 indexed citations
15.
Abbate, Ines, M. Correale, G Gargano, et al.. (1992). Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms.. PubMed. 13(1 Suppl). 92–6. 7 indexed citations
16.
Franco, Vito, Ada Maria Florena, Giovanni Guarneri, & G Gargano. (1991). Xanthogranulomatous salpingitis. Case report and review of the literature.. PubMed. 21(4). 197–9. 15 indexed citations
17.
Correale, M., et al.. (1991). Serum TAG 72 levels in different human carcinomas. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(1). 101–103. 2 indexed citations
18.
Gargano, G, et al.. (1990). Ovarian bilateral cystic teratomas: diagnosis and therapy in a young woman.. PubMed. 17(1). 37–42. 3 indexed citations
19.
Gargano, G, et al.. (1988). Antimicrobial prophylaxis for vaginal hysterectomy: comparison of two regimens.. PubMed. 15(4). 174–7. 1 indexed citations
20.
Greco, Pantaleo, et al.. (1987). Detailed ultrasound as a screening method for craniospinal abnormalities.. PubMed. 14(2). 115–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026